Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment

Core Insights - Eli Lilly's drug Mounjaro will be included in China's state-run health insurance scheme starting January 1 for type 2 diabetes patients [1] Group 1 - Mounjaro is a popular drug developed by Eli Lilly [1] - The inclusion in the health insurance scheme indicates a significant step for Eli Lilly in expanding its market presence in China [1] - The decision was announced by the National Healthcare Security Administration through a website notice [1]